Insights

Global Market Presence CSL operates in over 100 countries with a substantial workforce of more than 29,000 employees, indicating a broad geographic reach and diverse customer base that presents multiple regional sales opportunities across continents.

Diverse Portfolio With a focus on life-saving medicines, vaccines, and therapies in hematology and nephrology, CSL’s extensive product range offers numerous cross-selling and upselling prospects within the biopharmaceutical and healthcare sectors.

Technological Integration Utilizing advanced tools like SAS/GRAPH, Dynatrace, and VMware NSX, CSL emphasizes innovation and operational efficiency, creating opportunities for partnerships in digital health solutions, data analytics, and tech-driven healthcare services.

Financial Strength CSL’s robust revenue of approximately $10 billion along with active capital return strategies such as share buybacks and dividends signals financial stability, enabling potential collaborations and larger-scale enterprise deals.

Strategic Acquisitions Recent acquisitions and leadership expansions reflect CSL’s growth-focused approach, indicating opportunities to introduce complementary products, technologies, or services that align with their expansion and innovation strategies.

CSL Tech Stack

CSL uses 8 technology products and services including SAS/GRAPH, Open Graph, Sage X3, and more. Explore CSL's tech stack below.

  • SAS/GRAPH
    Business Intelligence
  • Open Graph
    Content Management System
  • Sage X3
    Enterprise Resource Planning
  • Dynatrace
    System Analytics & Monitoring
  • ComOps
    Time Tracking
  • Timesheets
    Time Tracking
  • Skype for Business
    Unified Communications
  • VMWare NSX
    Virtualisation Software

Media & News

CSL's Email Address Formats

CSL uses at least 2 format(s):
CSL Email FormatsExamplePercentage
First.Last@csl.com.auJohn.Doe@csl.com.au
92%
FLast@csl.com.auJDoe@csl.com.au
5%
First_Last@csl.com.auJohn_Doe@csl.com.au
1%
FirstMiddle.Last@csl.com.auJohnMichael.Doe@csl.com.au
1%
FL@csl.com.auJD@csl.com.au
1%
First.Last@csl.comJohn.Doe@csl.com
91%
FirstLast@csl.comJohnDoe@csl.com
6%
FirstL@csl.comJohnD@csl.com
3%

Frequently Asked Questions

Where is CSL's headquarters located?

Minus sign iconPlus sign icon
CSL's main headquarters is located at 655 Elizabeth St Melbourne, Victoria 3000 AU. The company has employees across 6 continents, including North AmericaOceaniaEurope.

What is CSL's phone number?

Minus sign iconPlus sign icon
You can contact CSL's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is CSL's stock symbol?

Minus sign iconPlus sign icon
CSL is a publicly traded company; the company's stock symbol is CSL.

What is CSL's official website and social media links?

Minus sign iconPlus sign icon
CSL's official website is csl.com and has social profiles on LinkedIn.

What is CSL's SIC code NAICS code?

Minus sign iconPlus sign icon
CSL's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does CSL have currently?

Minus sign iconPlus sign icon
As of October 2025, CSL has approximately 23K employees across 6 continents, including North AmericaOceaniaEurope. Key team members include Chief Commercial Officer (cco): A. S.Chief Operating Officer: M. O.Chief Health Officer And Vice President, Medical Affairs: G. C. S.. Explore CSL's employee directory with LeadIQ.

What industry does CSL belong to?

Minus sign iconPlus sign icon
CSL operates in the Biotechnology Research industry.

What technology does CSL use?

Minus sign iconPlus sign icon
CSL's tech stack includes SAS/GRAPHOpen GraphSage X3DynatraceComOpsTimesheetsSkype for BusinessVMWare NSX.

What is CSL's email format?

Minus sign iconPlus sign icon
CSL's email format typically follows the pattern of First.Last@csl.com.au. Find more CSL email formats with LeadIQ.

How much funding has CSL raised to date?

Minus sign iconPlus sign icon
As of October 2025, CSL has raised $111M in funding. The last funding round occurred on Feb 06, 2004 for $111M.
CSL

CSL

Biotechnology ResearchVictoria, Australia10001+ Employees

CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies.

Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest.

See our community guidelines: https://bit.ly/3Bs17Ra

Section iconCompany Overview

Headquarters
655 Elizabeth St Melbourne, Victoria 3000 AU
Phone number
Website
csl.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
CSL
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
10001+

Section iconFunding & Financials

  • $111M

    CSL has raised a total of $111M of funding over 1 rounds. Their latest funding round was raised on Feb 06, 2004 in the amount of $111M.

  • $10B

    CSL's revenue is estimated to be in the range of $10B

Section iconFunding & Financials

  • $111M

    CSL has raised a total of $111M of funding over 1 rounds. Their latest funding round was raised on Feb 06, 2004 in the amount of $111M.

  • $10B

    CSL's revenue is estimated to be in the range of $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.